Home › Bile Duct Cancer (Cholangiocarcinoma) › New York
Bile Duct Cancer (Cholangiocarcinoma) clinical trials in New York
15 studies for Bile Duct Cancer (Cholangiocarcinoma) are looking for participants at sites in New York.
Cities in New York
A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement
- Roswell Park Cancer Institute, Buffalo
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT06728410A Study of PHST001 in Advanced Solid Tumors
- START Center for Cancer Research - Long Island New York, Lake Success
- Mount Sinai, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT06840886A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- START New York Long Island LLC, Lake Success
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06270706A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
- Rosewell Park Comprehensive Cancer Center (Site 114), Buffalo
- Memorial Sloan Kettering Cancer Center (Site 108), New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07265674A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- New York University (NYU) Clinical Cancer Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07213791A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- START New York, Lake Success
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07488676Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
- Memorial Sloan Kettering Cancer Centers, New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT06282575Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- New York University Langone Health, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT05732831Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
- Memorial Sloan Kettering Commack - Limited Protocol Activities, Commack
- Memorial Sloan Kettering Westchester - Limited Protocol Activities, Harrison
- Memorial Sloan Kettering Cancer Center, New York
- and 1 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT04891289HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer
- Montefiore Medical Center, The Bronx
Recruiting
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT06899152Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
- New York Presbyterian Hospital-Columbia University Medical Center, New York
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT07486713A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 2
Ages 8 and older · All sexes · Updated Jul 27, 2026 · NCT05503797A Study of MGC028 in Participants With Advanced Solid Tumors
- Icahn School of Medicine at Mt. Sinai, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Apr 27, 2026 · NCT06723236SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Buffalo
- Massive Bio SYNERGY-AI site, Hempstead
- Massive Bio SYNERGY-AI site, Manhasset
- and 2 more
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774The Dragon PLC Trial (DRAGON-PLC)
- Memorial Sloan Kettering Cancer Center, New York
Recruiting
Ages 18 and older · All sexes · Updated May 15, 2025 · NCT06914648From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.